Table 3

Multivariate analysis of the prognostic factors

VariableHazard ratio
(95% CI)
p value
Treatment, PT vCT0.78 (0.60 to 1.01)0.0649
NYHA (class III and IV)1.40 (0.98 to 2.00)0.0620
Svo 2(/% increase)0.97 (0.95 to 0.99)0.0077
PVR (/wu increase)1.01 (0.99 to 1.04)0.3938
  • Multivariate analysis of the prognostic factors where p value is from the likelihood ratio test. The treatment effect does not quite achieve significance overall for the population.

  • PT, prostaglandin treatment; CT, conventional treatment; Svo 2 (mixed venous oxygen saturation) was a significant predictor; NYHA (New York Heart Association) grade just failed to reach significance; PVR (pulmonary vascular resistance) was not a significant predictor.